Despite Korea's new Covid-19 cases falling below 25,000 approximately half of the previous day (47,028), government officials remain alert over the virus's possible resurgence during the winter.On Monday, Korea reported 22,327 new Covid-19 infections, including 53 cases from overseas, bringing the t
About 30 percent of cancer-related content on social media, including YouTube, is misinformation not verified medically, a recent study showed.A research team, led by Professor Kwon Jeong-hye of the Hemato-oncology Department at Chungnam National University Sejong Hospital, said Monday that it publi
Celltrion said Monday it proved the effectiveness and safety of RemsimaSC (pipeline name: CT-P13 SC), an autoimmune disease treatment, in two global phase 3 trials. RemsimaSC is a subcutaneous injection (SC) form of infliximab, widely used in TNF-α inhibitor market. It is the world’s first inflixima
GC Pharma said on Monday that its neutropenia treatment, Neulapeg (ingredient: pegteograstim), confirmed effectiveness in a phase 2 study on patients with recurrent and refractory multiple myeloma.Neulapeg is a second-generation neutropenia treatment, which is an anticancer adjuvant that prevents he
CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent -- The Radiological Society of North America (RSNA) 2022 opened the world's largest radiological conference in Chicago, Ill, the U.S., on Sunday.Compared to last year, the convention was packed with participants and exhibitors as most Co
As poly ADP-ribose polymerase (PARP) inhibitors have recently seen their indications revoked or revised in the U.S., there is also a sign of changing approval details in Zejula (niraparib) in Korea, drawing the industry’s attention.According to anonymous sources on Monday, Takeda Korea is now consid
CGRP (calcitonin gene-related peptide) inhibitors, developed to prevent adult migraines, have recently been registered on the list of insurance beneficiaries, but their reimbursement standards are unrealistic, experts said.“The reimbursement criteria for CGRP inhibitors have been set by Western stan
Inventage Lab, a microfluidic drug delivery platform developer, said on Monday that its IVL4002, a recurrence-relieving multiple sclerosis treatment candidate, is scheduled to receive orphan drug designation (ODD) from the Ministry of Food and Drug Safety (MFDS).IVL4002, an investigational relapsing
Hanmi Pharmaceutical's U.S. partner, Spectrum, said that they would “deprioritize” poziotinib, its lung cancer treatment candidate, after receiving a CRL (Complete Response Letter) from the U.S. FDA at 6 a.m. (KST: 9 p.m.) on Friday.Poziotinib aims to treat non-small cell lung cancer (NSCLC) with lo
The government said on Friday that it will prepare a medical response plan to accommodate an outbreak of Covid-19 confirmed patients of around 200,000 a day expected in winter.Government and quarantine officials estimate that due to the inflow of new mutations and low level of additional vaccination
Daewoong Pharmaceutical held a symposium on Fexuclue, titled “The new wave of GERD (gastroesophageal reflux disease) Treatment,” on Thursday at its headquarters in Samseong-dong, southern Seoul.Thirty-eight “key opinion leaders” from overseas, including the leadership of the Philippine gastrointesti
The Korean Neurocritical Care Society (KNCS) has rolled up its sleeves to prepare for treating critical neurosis patients in the future.The society aims to neurointensivits, specialists who treat those patients, and expand independent neurocritical care units in tertiary general hospitals for the ne
JW Pharmaceutical said Friday that Ministry of Food and Drug Safety(MFDS) approved a multi-country phase 3 trial of epaminurad (pipeline name: URC102), a gout treatment.Epaminurad, developed as an oral pill, is a uric acid transporter-1 (URAT1) inhibitor. The company hopes that it could treat gout d
Qiagen Korea said on Friday it received domestic approval from the Ministry of Food and Drug Safety for Korea's first companion diagnostic (CDx) that can detect FGFR 3 (fibroblast growth factor receptor 3) gene mutations in urothelial cancer patients.On the same day, the MFDS approved Janssen Korea’
The Ministry of Food and Drug Safety approved Janssen Korea’s orphan drug, “Balversa (erdafitinib),” to treat urinary tract epithelial cancer on Thursday.Urinary tract epithelial cancer occurs in the epithelium (surface) of the urinary tract (through which urine passes), mostly in the bladder and oc
Spectrum Pharmaceuticals, Hanmi Pharmaceutical’s U.S. partner, said on Friday that it received a Complete Response Letter (CRL) from the FDA stating that the regulator needs supplementary data to approve poziotinib, a lung cancer treatment.As the FDA notification coincides with the Thanksgiving holi
Merz Aesthetics launched its Ulthera Asia-Pacific campaign featuring three star-studded Korean actors as ambassadors to promote the pursuit of individual beauty with the aesthetic lifting device on Thursday evening at Sebitseom Convention Center in Seoul.Merz Aesthetics Ulthera is a U.S. FDA-approve
People are usually sensitive to drugs’ adverse reactions rather than to their effectiveness. This is why many people turn to dietary supplements instead of medicines. Let’s take statin as an example. A statin is often used to lower the cholesterol level in the blood. According to a 2021 U.S. study,
With the recent slowdown in the spread of new confirmed cases in Korea, health experts have predicted that the peak of this winter epidemic may come earlier than expected.While the government had not made any specific predictions about the epidemic's peak this winter, many officials predicted that t
Eppendorf, a multinational life science company based in Germany, is renowned for systems in laboratories worldwide.The company provides a wide range of products and services required for running a laboratory, from consumables, such as pipettes, separation, and instrumentation equipment, to bioproce